- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips reorganizes U.S. staff
Philips Medical Systems North America has announced the first major set of organizational changes since Jack Price was promoted to president in March, replacing Michael Moakley (SCAN 3/19/97).Price selected Wade Binford, formerly group director of x-ray
Philips Medical Systems North America has announced the first major set of organizational changes since Jack Price was promoted to president in March, replacing Michael Moakley (SCAN 3/19/97).
Price selected Wade Binford, formerly group director of x-ray equipment operations at Philips, to take over his previous duties as vice president of marketing. Binford's slot was filled by Jan Smit, an imaging equipment veteran who formerly worked for Dornier Medical Systems and Toshiba America Medical Systems. Smit's family is associated with Philips subsidiary Smit-Roentgen, the German breast biopsy instrument manufacturer.
Philips also merged the operations of its MR, CT, and EasyGuide Neuro image-guided surgical workstation units. Christopher Farr, formerly MR marketing director, was appointed group director of MR/CT. His senior MR product manager, Paula Sanderson, was promoted to product manager of MR/CT.
Another senior MR product manager, Joe Nagle, was promoted to director of new MR/CT markets. Philips' former CT director Marc Lawrence was transferred to the company's global headquarters in Best, the Netherlands.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
